CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

Basit Öğe Kaydı
dc.authorwosidGarcia, Marc/KCK-9950-2024
dc.contributor.authorEsposito, F. M.
dc.contributor.authorLee, J.
dc.contributor.authorRha, S. Y.
dc.contributor.authorPenkov, K. D.
dc.contributor.authorMoisseev, A.
dc.contributor.authorVan den Eynde, M.
dc.contributor.authorPrenen, H.
dc.date.accessioned2024-08-04T20:57:20Z
dc.date.available2024-08-04T20:57:20Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- SEP 09-13, 2022 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.description.sponsorshipSanofien_US
dc.description.sponsorshipSanofi.en_US
dc.identifier.endpageS1124en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.issue7en_US
dc.identifier.startpageS1124en_US
dc.identifier.urihttps://hdl.handle.net/11616/102537
dc.identifier.volume33en_US
dc.identifier.wosWOS:000866211601522en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleCARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu